1. Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
    María Florencia Mercogliano et al, 2021, Cancers CrossRef
  2. Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis
    Carlo Augusto Mallio et al, 2021, Cancers CrossRef
  3. Exploring the Role of the Lymphatic System in Immune Regulation: Implications for Autoimmunity, Cancer, and Infection
    Marzieh Norouzian et al, 2023, Lymphatic System - From Human Anatomy to Clinical Practice CrossRef
  4. Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents
    E. V. Shubnikova et al, 2020, Safety and Risk of Pharmacotherapy CrossRef
  5. Hypocalcemia with Immune Checkpoint Inhibitors: The Disparity among Various Reports
    Swarna Sri Nalluru et al, 2020, International Journal of Endocrinology CrossRef
  6. Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve
    Kellsye P Fabian et al, 2021, Journal for ImmunoTherapy of Cancer CrossRef
  7. Immune Checkpoint Inhibitors and RAS–ERK Pathway-Targeted Drugs as Combined Therapy for the Treatment of Melanoma
    Marta Morante et al, 2022, Biomolecules CrossRef
  8. Tumor necrosis factor alpha neutralization attenuates immune checkpoint inhibitor-induced activation of intermediate monocytes in synovial fluid mononuclear cells from patients with inflammatory arthritis
    Anne Sofie Sørensen et al, 2022, Arthritis Research & Therapy CrossRef
  9. Mechanisms of Immunological Toxicity in Cancer Immunotherapy with Checkpoint Inhibitors
    Polaczek Mateusz Marek et al, 2023, Handbook of Cancer and Immunology CrossRef
  10. Complete and early response to cemiplimab associated to severe immune toxicity in advanced cervical cancer: a case report
    Anna Passarelli et al, 2023, Frontiers in Immunology CrossRef
  11. Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer
    Md. Mominur Rahman et al, 2022, Molecules CrossRef
  12. Drug-Associated Giant Cell Arteritis with Scalp Necrosis After Treatment with Pembrolizumab: a Case Report
    Bassel Bou Dargham et al, 2022, SN Comprehensive Clinical Medicine CrossRef
  13. Targeting Immunometabolism Mediated by CD73 Pathway in EGFR-Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune Resistance
    Anna Passarelli et al, 2020, Frontiers in Immunology CrossRef
  14. Association between Changes in the Patterns of Antinuclear Autoantibodies during Immune Checkpoint Inhibition Therapy and the Development of Severe Immune Related Adverse Events
    Leticia Alserawan et al, 2022, International Journal of Molecular Sciences CrossRef
  15. The Flip of the Coin of Personalized Cancer Immunotherapy: A Focused Review on Rare Immune Checkpoint Related Adverse Effects
    Nabil E. Omar et al, 2023, Immune Checkpoint Inhibitors - New Insights and Recent Progress CrossRef